We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Measuring what matters: advancing diversity, equity, and inclusion in lab medicine

By Jen A. Miller
Posted on 30 Jun 2026

Clinical laboratories play a key role in diagnosing and treating diseases and making meaningful contributions to patient outcomes. More...

But lab professionals can only provide equitable care if they understand how care varies across different demographics. Laboratories are best positioned to meet this need when they foster diversity, equity, and inclusion (DEI) among both their workforce and the patients they serve. In short, a laboratory workforce that is representative of the patient population it serves translates to better care.

At ADLM 2026, Jaime Noguez, PhD, DABCC, will moderate a scientific session on July 27 that explores how labs can meaningfully advance DEI efforts. Noguez, who is director of clinical chemistry and toxicology at University Hospitals Cleveland Medical Center and associate professor of pathology at Case Western Reserve University, said that achieving these goals requires far more than simply recognizing their importance.

“Laboratorians are often told why DEI matters, but rarely are we given guidance on how to operationalize those concepts in the laboratory environment,” said Noguez. “Our goal is to help laboratories move from simply having good intentions for DEI to actually having measurable action.”

The session, titled “Measuring what matters: a practical framework for advancing diversity, equity, and inclusion in lab medicine,” also features speakers Zahra Shajani-Yi, PhD, DABCC, FADLM, NRCC, voluntary associate clinical professor in the department of pathology at the University of California, San Diego, and Sean Campbell, PhD, DABCC, FADLM, adjunct associate professor in the department of pathology at the Albert Einstein College of Medicine and clinical biochemist at Sinai Health System.

Noguez, Shajani-Yi, and Campbell all serve on ADLM’s DEI Steering Committee. Together, they will present practical, evidence-based strategies for assessing and strengthening DEI efforts in clinical laboratory settings. Attendees will explore common barriers to achieving DEI, review real-world examples of successful initiatives, and learn how to apply a customizable scorecard to evaluate their own organizations and foster a community of inclusion and belonging.

The session will focus on three key areas. First, the speakers will introduce meaningful DEI metrics that clinical laboratories can use to guide decision-making and track progress. The name of the session is intentional in that way. “When we chose the phrase [“Measuring what matters”] for our title, in this context it means looking at meaningful indicators rather than simply counting DEI-related activities,” Noguez said. 

Next, the presenters will address DEI among clinical laboratory workers. “We face significant workforce shortages and are trying to attract more individuals to a career in laboratory medicine. Creating an inclusive environment is essential not only for recruitment but also for long-term retention,” Noguez said.

Finally, the speakers will talk about DEI-related patient care gaps and share examples of successful efforts to fill them. 

Designed as an interactive experience rather than a traditional lecture, this session will integrate audience polling and scenario-based discussions that panelists and attendees will participate in together. “We’re allowing participants to apply concepts we’re talking about in real time and learn from peers facing similar challenges,” said Noguez. 

The session is for people in various roles across the clinical laboratory, including leaders, pathologists, and front-line laboratorians. “It is intended for anyone who wants to strengthen organizational culture while also improving patient care,” Noguez said.

Overall, instead of just talking about DEI as an abstract concept, the speakers aim to inspire action. “We want to help clinical laboratorians understand how DEI efforts tie directly to metrics and connect metrics to tangible improvements in patient care,” Noguez said.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Platelet Function Analyzer
PL-12
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

Inherited cancer risk can influence diagnosis, treatment planning, and family screening, yet current testing practices often depend on a patient’s age at diagnosis. Many patients undergo germline genetic... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.